Structural Heart News Today

ADAGIO MEDICAL Investor Presentation | June 2024 1 DISCLAIMER This investor presentation is for informational purposes only to assist interested parties in making their...

Edwards Lifesciences (NYSE: EW) today announced data supporting the use of its transcatheter aortic valve replacement (TAVR) in women.

NEWS RELEASE Contacts: Erika Winkels Public Relations +1-763-526-8478 ...

FINAL Q4 FY24 Earnings call commentary Ryan Weispfenning Good...

Medtronic reported Q4 2024 sales of $8.59 billion, with 0.5% reported and 5.4% organic revenue growth. Dividend increased to $0.70 per share. FY 2025 EPS guidance is $5.40-$5.50.

Heart disease is the leading cause of death for women, but a new study showed 65 percent of women who have high risk factors, are not even referred to specialists. The top doctors in the field admit big changes need to happen fast before more women fall through the cracks.

Press Release Thubrikar Aortic Valve, Inc. today announced successful results in the first two patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) using the new Precision 2™ Delivery Catheter. Interventional Cardiologist and TAVI-1 Study…

Company expands structural heart portfolio and begins the limited market release of a bipolar temporary pacing guidewire intended to introduce and position catheters and other interventional devices within the chambers of the heart while transmitting an electrical signal from an external pulse generator to the heart

Medtronic (NYSE: MDT) today announced the release of new data for its transcatheter heart valve therapy technologies.

Teleflex (NYSE: TFX) this week announced the limited market release of its Wattson Temporary Pacing Guidewide.